Association of Glutathione S-Transferase T1, M1, and P1 Polymorphisms in the Breast Cancer Risk: A Meta-Analysis

Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s104339
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Combined Effects of Glutathione S-Transferase M1 and T1 Polymorphisms on Risk of Lung Cancer: Evidence From a Meta-Analysis

Oncotarget
Oncology
2017English

Association Between Glutathione S-Transferase M1/T1 Gene Polymorphisms and Susceptibility to Endometriosis: A Systematic Review and Meta-Analysis

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2016English

Polymorphisms of Glutathione S-Transferase M1, T1 and P1 in Patients With Reflux Esophagitis and Barrett’s Esophagus

Journal of Human Genetics
Genetics
2007English

Association Between Polycystic Ovary Syndrome and the Polymorphisms of Aryl Hydrocarbon Receptor Repressor, Glutathione-S-Transferase T1, and Glutathione-S-Transferase M1 Genes

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2018English

Glutathione S-Transferase P1 Ile105Val Polymorphism and Breast Cancer Risk: Convergence and Divergence of the Two Recent Meta-Analyses

Breast Cancer Research and Treatment
Cancer ResearchOncology
2010English

Polymorphisms of the Glutathione S-Transferase P1 Gene and Head and Neck Cancer Susceptibility

Head and Neck
Otorhinolaryngology
2002English

Glutathione S-Transferase Polymorphisms and Risk of Ovarian Cancer: A HuGE Review

Genetics in Medicine
MedicineGenetics
2002English

Glutathione S-Transferase M1 and T1 Gene Polymorphism in Patients With Lung Cancer Among Turkish Population

Biotechnology and Biotechnological Equipment
Biotechnology
2001English

Glutathione S-Transferase Polymorphisms: Cancer Incidence and Therapy

Oncogene
Cancer ResearchGeneticsMolecular Biology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy